New uses of preimplantation genetic diagnosis (PGD) to screen embryos prior to transfer raise ethical, legal, and policy issues that deserve close attention. Extensions for medical purposes, such as to identify susceptibility genes, late onset disease, and human leukocyte antigen (HLA) matching, are usually ethically acceptable. Whether embryo screening for gender, perfect pitch, or other non-m...

A series of new technologies and adjuvant therapies have been advocated in order to improve the success of IVF treatment. Dehydro-epiandrostenedione, growth hormones, Coenzyme Q 10, calcium ionosphores, immune therapy, heparin, low-dose aspirin, and vasodilators are among commonly prescribed pharmacological adjuvants. New technologies that are proposed to improve IVF outcomes include advanced s...

Title: Expanded carrier screening and preimplantation genetic diagnosis in a couple who delivered a baby affected with congenital factor VII deficiency Authors: Wen-Bin He ([email protected]) Yue-Qiu Tan ([email protected]) Xiao Hu ([email protected]) Wen Li ([email protected]) Bo Xiong ([email protected]) Ke-Li Luo ([email protected]) Fei Gong ([email protected]) Guang-Xiu Lu (lgxdirector@sin...

In this issue of RBM Online, two independent studies, Feng et al. (2012) and Lathi et al. (2012), confirm the conclusions of an earlier cohort study on comparative genomic hybridization (CGH) after trophectoderm biopsy and vitrification (Schoolcraft et al., 2010). Feng and co-workers demonstrate that vitrification and warming of blastocysts has minimal effect on their viability, while Lathi and...